Proximal total splenic artery embolization for refractory hepatic encephalopathy

Clin J Gastroenterol. 2018 Apr;11(2):156-160. doi: 10.1007/s12328-017-0805-5. Epub 2017 Dec 1.

Abstract

A Japanese woman with a history of Kasai operation for biliary atresia had living-donor liver transplantation at the age of 22. The first episode of refractory HE and late cellular rejection was treated by a high dose of methylprednisolone. The second episode of refractory HE was treated by balloon-occluded retrograde transvenous obliteration for a spleno-renal shunt. However, the third episode of refractory HE occurred 11 years after liver transplantation. The liver cirrhosis and hypersplenism were present with a Child-Pugh score of C-10. Although portal vein flow was hepatopetal, superior mesenteric vein flow regurgitated. We performed proximal total splenic artery embolization (TSAE). Superior mesenteric vein flow changed to a hepatopetal direction and she became clear. At a year after proximal TSAE, her spleen volume had decreased to 589 mL (20% decrease) on computed tomography. She is well and has a Child-Pugh score of 8 without overt HE. We report the first case of refractory HE treated by proximal TSAE that is a possible less invasive treatment option for a selected patient.

Keywords: Hepatofugal; Living-donor liver transplantation; Proximal total splenic artery embolization; Refractory hepatic encephalopathy; Superior mesenteric vein.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Embolization, Therapeutic / methods*
  • Female
  • Hepatic Encephalopathy / etiology
  • Hepatic Encephalopathy / therapy*
  • Humans
  • Liver Transplantation / adverse effects
  • Living Donors
  • Postoperative Complications / therapy
  • Recurrence
  • Splenic Artery*
  • Treatment Outcome